FIVE YEARS OF FOLLOW-UP FROM THE PHASE 3 RESONATE-2 STUDY AND NURSING EXPERIENCE WITH PATIENTS RECEIVING FIRST-LINE IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0

作者：

Greenberg, Edythe M. ^{[1
]}

Settlemire, Milan ^{[2
]}

Lal, Indu ^{[3
]}

Amaya-Chanaga, Carlos ^{[3
]}

Coutre, Steven ^{[2
]}

Burger, Jan A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA

[3] Pharmacyclics LLC, Sunnyvale, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

178

引用

页数：2